Merck & Company Inc (1MRKX)

Milan


	Symbol		Exchange		Currency
	MRK		NYSE		USD	Real-time
	0QAH		London		USD	Real-time
	MRK		Mexico		MXN	Delayed
	1MRKX		Milan		EUR	Real-time
	MRK		Xetra		EUR	Delayed
	MRK		TradeGate		EUR	Delayed
	MRK		Frankfurt		EUR	Delayed
	MRKm		Buenos Aires		ARS	Delayed
	MRCK34		B3		BRL	Delayed
	MRK		Vienna		EUR	Real-time
	MRK		Ukraine		UAH	Delayed
	MRK		Lima		USD	Delayed

Currency in EUR

Disclaimer

100.20

0.00(0.00%)

Real-time Data14/10

Fair Value

Day's Range

100.20

101.20

52 wk Range

91.80

126.40

1MRKX Income Statement

Featured here, the Income Statement (earnings report) for Merck & Company Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

16,152

17,534

19,687

22,232

20,993

Total Revenues Growth

+8.87%

+8.56%

+12.28%

+12.93%

-5.57%

Cost Of Revenues

5,951

6,782

7,325

8,500

8,558

Gross Profit

10,201

10,752

12,362

13,732

12,435

Gross Profit Growth

+7.45%

+5.4%

+14.97%

+11.08%

-9.45%

Gross Profit Margin %

63.16%

61.32%

62.79%

61.77%

59.23%

Other Operating Expenses, Total

7,648

7,681

8,056

8,754

8,740

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+1.76%	+0.43%	+4.88%	+8.66%	-0.16%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,239	2,262	2,418	2,447	2,439
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,669	5,300	5,461	5,982	5,786
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-260	119	177	325	515

Operating Income

2,553

3,071

4,306

4,978

3,695

Operating Income Growth

+29.07%

+20.29%

+40.21%

+15.61%

-25.77%

EBIT Margin %

15.81%

17.51%

21.87%

22.39%

17.6%

Net Interest Expenses

-337

-289

-199

-125

-88

Net Interest Expenses Growth

-58.22%

+14.24%

+31.14%

+37.19%

+29.6%

Interest Expense, Total

-403

-328

-245

-196

-260

Interest And Investment Income

66

39

46

71

172

Other Non Operating Expenses, Total

-87

-58

-20

-112

77

EBT, Excl. Unusual Items

2,129

2,724

4,087

4,741

3,684

Gain (Loss) On Sale Of Assets

30

94

63

45

132

Other Unusual Items, Total

-84

173

-85

-299

-84

EBT, Incl. Unusual Items

1,735

2,631

3,924

4,288

3,484

EBT, Incl. Unusual Items Growth

+18.75%

+51.64%

+49.14%

+9.28%

-18.75%

EBT, Incl. Unusual Items Margin

10.74%

15.01%

19.93%

19.29%

16.6%

Income Tax Expense

440

637

859

948

650

Net Income to Company

1,323

1,994

3,065

3,340

2,834

Minority Interest

-3

-7

-10

-14

-10

Net Income

1,320

1,987

3,055

3,326

2,824

Net Income Growth

-60.88%

+50.53%

+53.75%

+8.87%

-15.09%

Net Income Margin %

8.17%

11.33%

15.52%

14.96%

13.45%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

1,292

1,987

3,055

3,326

2,824

Basic EPS - Continuing Operations

2.97

4.57

7.03

7.65

6.5

Basic EPS - Continuing Operations Growth

+20.63%

+53.79%

+53.75%

+8.87%

-15.09%

Diluted EPS - Continuing Operations

2.97

4.57

7.03

7.65

6.49

Diluted EPS - Continuing Operations Growth

+20.57%

+53.87%

+53.75%

+8.87%

-15.16%

Basic Weighted Average Shares Outstanding

434.78

434.78

434.78

434.78

434.78

Diluted Weighted Average Shares Outstanding

434.78

434.78

434.78

434.78

434.78

Dividend Per Share

1.3

1.4

1.85

2.2

2.2

Dividend Per Share Growth

+4%

+7.69%

+32.14%

+18.92%

0%

EBITDA

4,234

4,591

5,788

6,522

5,226

EBITDA Growth

+15.21%

+8.43%

+26.07%

+12.68%

-19.87%

EBITDA Margin %

26.21%

26.18%

29.4%

29.34%

24.89%

EBIT